AKEBIA THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
AKEBIA THERAPEUTICS, INC. (AKBA) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 161.33 million shares for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-08-05
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 161.33M shares, a 17.84% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 153.82M shares, a 19.80% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 145.11M shares, a 21.58% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 143.31M shares, a 20.57% increase year-over-year.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 138.46M shares, a 16.95% increase from fiscal 2019.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 118.40M shares, a 104.00% increase from fiscal 2018.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 58.04M shares, a 33.42% increase from fiscal 2017.
- AKEBIA THERAPEUTICS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 43.50M shares, a 15.33% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 85 month |
|---|---|---|---|---|---|
| 2021-06-30 | 161.33M shares 10-Q · filed 2021-08-05 | 157.60M shares 10-Q · filed 2021-08-05 | 153.42M shares derived: average of 3 quarters · filed 2021-08-05 | 150.89M shares derived: average of 4 quarters · filed 2021-08-05 | |
| 2021-03-31 | 153.82M shares 10-Q · filed 2021-05-10 | 149.47M shares derived: average of 2 quarters · filed 2021-05-10 | 147.42M shares derived: average of 3 quarters · filed 2021-05-10 | 144.79M shares derived: average of 4 quarters · filed 2021-08-05 | |
| 2020-12-31 | 145.11M shares 10-K · filed 2021-02-25 | 144.21M shares derived: average of 2 quarters · filed 2021-02-25 | 141.78M shares derived: average of 3 quarters · filed 2021-08-05 | 138.46M shares 10-K · filed 2021-02-25 | |
| 2020-09-30 | 143.31M shares 10-K · filed 2021-02-25 | 140.11M shares derived: average of 2 quarters · filed 2021-08-05 | 136.23M shares 10-Q · filed 2020-11-05 | 131.99M shares derived: average of 4 quarters · filed 2021-08-05 | |
| 2020-06-30 | 136.91M shares 10-Q · filed 2021-08-05 | 132.65M shares 10-Q · filed 2021-08-05 | 128.22M shares derived: average of 3 quarters · filed 2021-08-05 | 125.88M shares derived: average of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | 128.40M shares 10-Q · filed 2021-05-10 | 123.88M shares derived: average of 2 quarters · filed 2021-05-10 | 122.21M shares derived: average of 3 quarters · filed 2021-05-10 | 121.22M shares derived: average of 4 quarters · filed 2021-05-10 | |
| 2019-12-31 | 119.36M shares 10-K · filed 2021-02-25 | 119.11M shares derived: average of 2 quarters · filed 2021-02-25 | 118.83M shares derived: average of 3 quarters · filed 2021-02-25 | 118.40M shares 10-K · filed 2021-02-25 | |
| 2019-09-30 | 118.86M shares 10-K · filed 2021-02-25 | 118.57M shares derived: average of 2 quarters · filed 2021-02-25 | 118.07M shares 10-Q · filed 2020-11-05 | 105.90M shares derived: average of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | 118.27M shares 10-K · filed 2021-02-25 | 117.67M shares 10-Q · filed 2020-08-10 | 101.58M shares derived: average of 3 quarters · filed 2021-02-25 | 90.44M shares derived: average of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | 117.06M shares 10-K · filed 2021-02-25 | 93.23M shares derived: average of 2 quarters · filed 2021-02-25 | 81.17M shares derived: average of 3 quarters · filed 2021-02-25 | 75.10M shares derived: average of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | 69.40M shares 10-K · filed 2020-03-12 | 63.22M shares derived: average of 2 quarters · filed 2020-03-12 | 61.11M shares derived: average of 3 quarters · filed 2020-03-12 | 58.04M shares 10-K · filed 2021-02-25 | |
| 2018-09-30 | 57.03M shares 10-K · filed 2020-03-12 | 56.96M shares derived: average of 2 quarters · filed 2020-03-12 | 54.21M shares 10-Q · filed 2019-11-12 | 52.48M shares derived: average of 4 quarters · filed 2020-03-12 | |
| 2018-06-30 | 56.89M shares 10-K · filed 2020-03-12 | 52.77M shares 10-Q · filed 2019-08-08 | 50.97M shares derived: average of 3 quarters · filed 2020-03-12 | 49.96M shares derived: average of 4 quarters · filed 2020-03-12 | |
| 2018-03-31 | 48.61M shares 10-K · filed 2020-03-12 | 48.00M shares derived: average of 2 quarters · filed 2020-03-12 | 47.65M shares derived: average of 3 quarters · filed 2020-03-12 | 45.94M shares derived: average of 4 quarters · filed 2020-03-12 | |
| 2017-12-31 | 47.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 47.17M shares derived: average of 2 quarters · filed 2020-03-12 | 45.05M shares derived: average of 3 quarters · filed 2020-03-12 | 43.50M shares 10-K · filed 2020-03-12 | |
| 2017-09-30 | 46.94M shares 10-Q · filed 2018-11-08 | 43.88M shares derived: average of 2 quarters · filed 2018-11-08 | 42.20M shares 10-Q · filed 2018-11-08 | 41.20M shares derived: average of 4 quarters · filed 2019-03-26 | |
| 2017-06-30 | 40.82M shares 10-Q · filed 2018-08-08 | 39.80M shares 10-Q · filed 2018-08-08 | 39.29M shares derived: average of 3 quarters · filed 2019-03-26 | 38.94M shares derived: average of 4 quarters · filed 2019-03-26 | |
| 2017-03-31 | 38.76M shares 10-Q · filed 2018-05-09 | 38.52M shares derived: average of 2 quarters · filed 2019-03-26 | 38.31M shares derived: average of 3 quarters · filed 2019-03-26 | 38.19M shares derived: average of 4 quarters · filed 2019-03-26 | |
| 2016-12-31 | 38.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | 38.09M shares derived: average of 2 quarters · filed 2019-03-26 | 38.00M shares derived: average of 3 quarters · filed 2019-03-26 | 37.72M shares 10-K · filed 2019-03-26 | |
| 2016-09-30 | 37.90M shares 10-Q · filed 2017-11-08 | 37.85M shares derived: average of 2 quarters · filed 2017-11-08 | 37.53M shares 10-Q · filed 2017-11-08 | 35.73M shares derived: average of 4 quarters · filed 2018-03-12 | |
| 2016-06-30 | 37.81M shares 10-Q · filed 2017-08-08 | 37.34M shares 10-Q · filed 2017-08-08 | 35.01M shares derived: average of 3 quarters · filed 2018-03-12 | 33.46M shares derived: average of 4 quarters · filed 2018-03-12 | |
| 2016-03-31 | 36.87M shares 10-Q · filed 2017-05-09 | 33.61M shares derived: average of 2 quarters · filed 2018-03-12 | 32.00M shares derived: average of 3 quarters · filed 2018-03-12 | 30.66M shares derived: average of 4 quarters · filed 2018-03-12 | |
| 2015-12-31 | 30.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | 29.57M shares derived: average of 2 quarters · filed 2018-03-12 | 28.58M shares derived: average of 3 quarters · filed 2018-03-12 | 26.47M shares 10-K · filed 2018-03-12 | |
| 2015-09-30 | 28.78M shares 10-Q · filed 2016-11-09 | 27.70M shares derived: average of 2 quarters · filed 2016-11-09 | 25.18M shares 10-Q · filed 2016-11-09 | 23.82M shares derived: average of 4 quarters · filed 2017-03-06 | |
| 2015-06-30 | 26.61M shares 10-Q · filed 2016-08-08 | 23.34M shares 10-Q · filed 2016-08-08 | 22.17M shares derived: average of 3 quarters · filed 2017-03-06 | 21.55M shares derived: average of 4 quarters · filed 2017-03-06 | |
| 2015-03-31 | 20.03M shares 10-Q · filed 2016-05-05 | 19.95M shares derived: average of 2 quarters · filed 2017-03-06 | 19.86M shares derived: average of 3 quarters · filed 2017-03-06 | 19.81M shares derived: average of 4 quarters · filed 2017-03-06 | |
| 2014-12-31 | 19.86M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | 19.78M shares derived: average of 2 quarters · filed 2017-03-06 | 19.74M shares derived: average of 3 quarters · filed 2017-03-06 | 15.41M shares 10-K · filed 2017-03-06 | |
| 2014-09-30 | 19.69M shares 10-Q · filed 2015-11-09 | 19.67M shares derived: average of 2 quarters · filed 2015-11-09 | 13.92M shares 10-Q · filed 2015-11-09 | 10.55M shares derived: average of 4 quarters · filed 2016-03-14 | |
| 2014-06-30 | 19.65M shares 10-Q · filed 2015-08-11 | 10.99M shares 10-Q · filed 2015-08-11 | 7.51M shares derived: average of 3 quarters · filed 2016-03-14 | 5.77M shares derived: average of 4 quarters · filed 2016-03-14 | |
| 2014-03-31 | 2.23M shares 10-Q · filed 2015-05-11 | 1.44M shares derived: average of 2 quarters · filed 2016-03-14 | 1.14M shares derived: average of 3 quarters · filed 2016-03-14 | 981.59K shares derived: average of 4 quarters · filed 2016-03-14 | 338.93K shares 10-Q · filed 2014-05-12 |
| 2013-12-31 | 647.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | 597.22K shares derived: average of 2 quarters · filed 2016-03-14 | 566.44K shares derived: average of 3 quarters · filed 2016-03-14 | 544.00K shares 10-K · filed 2016-03-14 | |
| 2013-09-30 | 546.71K shares 10-Q · filed 2014-11-10 | 525.79K shares derived: average of 2 quarters · filed 2014-11-10 | 509.43K shares 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | 504.87K shares 10-Q · filed 2014-08-11 | 490.47K shares 10-Q · filed 2014-08-11 | |||
| 2013-03-31 | 475.92K shares 10-Q · filed 2014-05-12 | ||||
| 2012-12-31 | 414.11K shares 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |